Wygląda na to, że wystąpił błąd podczas próby wczytania tej strony.
Nasz zespół został powiadomiony, ale jeśli problem nie ustąpi, skontaktuj się z nami, korzystając z widżetu widżet e-mail wsparcia.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | Yes | No |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Kukje Pharma Co., Ltd. |
KOREA PHARMA Co., Ltd. |
Jin Yang Pharmaceutical Co., Ltd. |
Korean Drug Co., Ltd. |
MYUNGMOON Pharm co.,Ltd |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
A002720 | A032300 | A007370 | A014570 | A017180 | A307750 | |||
Return On Equity | ||||||||
Latest Twelve Months | 6% | 5% | 28% | 4% | -3% | 2% | ||
Fiscal Year - 1 | -11% | 0% | 15% | -6% | -5% | 5% | ||
Fiscal Year - 2 | 5% | -2% | 17% | 15% | 9% | 10% | ||
Fiscal Year - 3 | -2% | 12% | 17% | 12% | -8% | 5% | ||
Fiscal Year - 4 | 3% | 9% | 11% | 11% | -34% | NA | ||
Fiscal Year - 5 | -7% | 23% | 4% | 6% | -25% | NA | ||
Average | -1% | 8% | 15% | 7% | -11% | 6% | ||
Median | 1% | 7% | 16% | 8% | -7% | 5% | ||
Benchmarks | Ticker | |||||||
Kukje Pharma Co., Ltd. | KOSE:A002720 | |||||||
KOREA PHARMA Co., Ltd. | KOSDAQ:A032300 | |||||||
Jin Yang Pharmaceutical Co., Ltd. | KOSDAQ:A007370 | |||||||
Korean Drug Co., Ltd. | KOSDAQ:A014570 | |||||||
MYUNGMOON Pharm co.,Ltd | KOSE:A017180 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | A002720 | A032300 | A007370 | A014570 | A017180 | A307750 | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 156,463 | 81,277 | 113,332 | 73,001 | 186,443 | 136,468 | ||
Fiscal Year | 156,463 | 81,277 | 113,332 | 73,001 | 186,443 | 136,468 | ||
Fiscal Year - 1 | 135,373 | 83,240 | 93,708 | 81,375 | 169,567 | 121,998 | ||
Fiscal Year - 2 | 126,583 | 81,029 | 76,264 | 79,984 | 152,135 | 103,711 | ||
Fiscal Year - 3 | 119,746 | 79,577 | 62,839 | 74,466 | 137,760 | 85,354 | ||
Fiscal Year - 4 | 130,395 | 71,510 | 49,525 | 66,789 | 127,853 | NA | ||
Fiscal Year - 5 | 111,122 | 66,136 | 47,351 | 55,529 | 149,346 | NA | ||
Net Income | ||||||||
Latest Twelve Months | 5,205 | 3,792 | 29,694 | 2,995 | (3,035) | 1,736 | ||
Fiscal Year | 5,205 | 3,792 | 29,694 | 2,995 | (3,035) | 1,736 | ||
Fiscal Year - 1 | (8,415) | 84 | 12,340 | (4,917) | (4,525) | 4,824 | ||
Fiscal Year - 2 | 3,557 | (1,119) | 12,308 | 11,809 | 7,868 | 8,948 | ||
Fiscal Year - 3 | (1,559) | 6,368 | 9,538 | 9,042 | (6,865) | 4,038 | ||
Fiscal Year - 4 | 2,203 | 3,159 | 5,229 | 7,360 | (27,639) | NA | ||
Fiscal Year - 5 | (4,761) | 5,528 | 1,647 | 3,895 | (20,402) | NA | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 163,259 | 121,303 | 119,907 | 89,709 | 236,549 | 225,102 | ||
Latest Fiscal Quarter | 165,548 | 112,387 | 227,574 | 88,887 | 257,988 | 212,273 | ||
Fiscal Year | 165,548 | 112,387 | 227,574 | 88,887 | 257,988 | 212,273 | ||
Fiscal Year - 1 | 163,259 | 121,303 | 119,907 | 89,709 | 236,549 | 225,102 | ||
Fiscal Year - 2 | 136,593 | 130,947 | 114,444 | 94,516 | 230,450 | 196,097 | ||
Fiscal Year - 3 | 139,783 | 129,401 | 98,502 | 88,613 | 223,263 | 106,989 | ||
Fiscal Year - 4 | 145,626 | 81,320 | 71,591 | 83,345 | 243,025 | NA | ||
Fiscal Year - 5 | 134,594 | 66,747 | 68,278 | 75,850 | 264,442 | NA | ||
Fiscal Year - 6 | 126,235 | 62,231 | 70,061 | 72,962 | 243,066 | NA | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 84,944 | 68,582 | 88,758 | 77,090 | 83,453 | 96,422 | ||
Latest Fiscal Quarter | 89,542 | 71,441 | 119,878 | 78,106 | 96,851 | 97,420 | ||
Fiscal Year | 89,542 | 71,441 | 119,878 | 78,106 | 96,851 | 97,420 | ||
Fiscal Year - 1 | 84,944 | 68,582 | 88,758 | 77,090 | 83,453 | 96,422 | ||
Fiscal Year - 2 | 74,074 | 59,815 | 77,575 | 84,713 | 89,522 | 91,597 | ||
Fiscal Year - 3 | 68,568 | 57,467 | 65,318 | 76,690 | 80,257 | 83,150 | ||
Fiscal Year - 4 | 70,482 | 46,502 | 48,270 | 70,871 | 87,201 | NA | ||
Fiscal Year - 5 | 60,929 | 26,598 | 43,666 | 65,050 | 76,510 | NA | ||
Fiscal Year - 6 | 68,672 | 22,241 | 42,048 | 62,799 | 89,680 | NA |